Alnylam price target raised to $342 from $291 at Citi

Citi analyst David Lebowitz raised the firm’s price target on Alnylam to $342 from $291 and keeps a Buy rating on the shares. Alnylam reported Q2 results that substantially beat Street estimates, prompting the company to raise its guidance for both net product revenues, as well as revenue from collaborations and royalties, the analyst tells investors in a research note.